Date  |
|
| Sep 15, 2021 |
9 Meters Biopharma, Inc. to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit |
| Sep 22, 2021 |
9 Meters Biopharma, Inc. to Present at the Cantor Virtual Global Healthcare Conference |
| Sep 27, 2021 |
9 Meters Biopharma, Inc. Announces Partnership with Non-Profit Gluten-Free Food Pantry Organization Mend Hunger |
| Oct 4, 2021 |
9 Meters Biopharma, Inc. Appoints Samantha Ventimiglia to Board of Directors |
| Oct 19, 2021 |
9 Meters Biopharma, Inc. to Present Data on Therapeutic Candidate in Short Bowel Syndrome at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting |
| Oct 26, 2021 |
9 Meters Biopharma, Inc. Presents Pharmacokinetic Data from Phase 1b/2a Study with Vurolenatide, Currently in Phase 2 for Short Bowel Syndrome, at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting |
| Nov 9, 2021 |
9 Meters Biopharma, Inc. to Present at the 12th Annual Jefferies London Healthcare Conference |
| Nov 10, 2021 |
9 Meters Biopharma, Inc. Announces Immuno-Oncology Collaboration with Gustave Roussy for NM-102, a Gut Microbiome Modulator |
| Nov 15, 2021 |
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021 |
| Dec 15, 2021 |
9 Meters Biopharma, Inc. Awards Unrestricted Educational Grant Funding to Carol Rees Parrish, M.S., RDN, for Short Bowel Syndrome Education |